revefenacin Nebuliser solution 175 mcg - 3 ml
This fully integrated specialty pharmaceutical company focuses on researching, manufacturing, and marketing respiratory drug products globally. Their therapeutic areas include allergic rhinitis, asthma, COPD, respiratory infections, pulmonary fibrosis, and pulmonary hypertension. They offer various dosage forms, including inhalation sprays (SMI), metered-dose inhalers (MDI), dry powder inhalers (DPI), nebulizations, nasal sprays, and liposomes. The company boasts over 30 patents and a team of more than 100 R&D personnel. They have received recognition as a top employer in their region and secured significant funding to support the development of high-end inhalation products. Their operations extend across key regions like the EU and North America.